KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Neogenomics (NEO) over the last 16 years, with Q3 2025 value amounting to $155.3 million.

  • Neogenomics' Receivables - Net rose 255.43% to $155.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.3 million, marking a year-over-year increase of 255.43%. This contributed to the annual value of $150.5 million for FY2024, which is 1471.72% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Receivables - Net is $155.3 million, which was up 255.43% from $153.1 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Receivables - Net peaked at $155.3 million during Q3 2025, and registered a low of $102.9 million during Q1 2021.
  • Moreover, its 5-year median value for Receivables - Net was $125.4 million (2023), whereas its average is $128.2 million.
  • Data for Neogenomics' Receivables - Net shows a peak YoY increase of 2109.93% (in 2021) and a maximum YoY decrease of 122.18% (in 2021) over the last 5 years.
  • Over the past 5 years, Neogenomics' Receivables - Net (Quarter) stood at $112.1 million in 2021, then increased by 6.76% to $119.7 million in 2022, then grew by 9.62% to $131.2 million in 2023, then increased by 14.72% to $150.5 million in 2024, then increased by 3.16% to $155.3 million in 2025.
  • Its Receivables - Net stands at $155.3 million for Q3 2025, versus $153.1 million for Q2 2025 and $151.2 million for Q1 2025.